Global Health Matters

17 January 2019 - By Thomas B. Cueni
This oped was published first on IP Watch on 16 January 2019 The views expressed in this article are solely those of the authors and are not associated with Intellectual Property Watch. IP-Watch expressly disclaims and refuses any responsibility or liability for the content, style or form of any posts ...
Read More
11 January 2019 - By Greg Perry
For millions of people worldwide out-of-pocket health expenses translate to out-of-reach opportunities for the future. Children miss out on essential immunizations, women die giving birth in unsafe environments, and people are at risk of going blind or having a stroke before they realize they are not properly controlling their diabetes. ...
Read More
18 December 2018 - By Thomas B. Cueni
This oped was first published on IAPO Newsletter on 17 December 2018. An efficient healthcare system depends on mutual trust between patients, healthcare professionals, regulators and pharmaceutical companies – but how should that translate concretely into the day to day reality of whether a healthcare professional should be given a ...
Read More
13 December 2018 - By Thomas B. Cueni
This oped was first published first on PharmaBoardroom on 12 December 2018.   At least half of the world’s population cannot obtain essential health services, according to a 2017 report from the World Bank and World Health Organization[1]. And each year, large numbers of households are being pushed into poverty ...
Read More
6 December 2018 - By Thomas B. Cueni
This oped was first published in The Pharma Letter on 6 December 2018. Business performance is mostly about the tangible: robust pipeline, successful launches, development of sales, financial results, profit margins, and the like. One less tangible but absolutely crucial measure of success relates to “how” we go about our ...
Read More
13 November 2018 - By Thomas B. Cueni
This oped was first published in the Antimicrobial Resistance campaign in the Guardian on 12 November 2018   Antimicrobial resistance (AMR) is on course to overtake cancer and account for 10m deaths a year by 2050. Already, 700,000 people die from drug-resistant infections (“superbugs”) each year. AMR could cost the ...
Read More
26 October 2018 - By Thomas B. Cueni
This oped was first published on AGEGI on 25 October 2018. Résumé : Avec Ebola chaque pays est vulnérable face aux épidémies et la solution passe par une couverture universelle de santé et un travail collectif Même si l’Organisation Mondiale de la Santé (OMS) a récemment décidé qu’il n’y a pas ...
Read More
4 October 2018 - By Thomas B. Cueni
This oped was first published in the World Medical Journal (Vol. 64, September2018). An efficient healthcare system depends on mutual trust between all parties – but how should that translate concretely into the day to day reality of whether a healthcare professional should be given a subscription to a journal ...
Read More
28 September 2018 - By Thomas B. Cueni
This oped was first published on Health Policy Watch on 28 September 2018. It’s often hard to see progress when the realities surrounding you are bleak: non-communicable diseases (NCDs) are the world’s biggest killer, responsible for around 70 percent of global deaths. Each year some 40 million people die of ...
Read More
26 September 2018 - By Thomas B. Cueni
This interview was first published on Pharma Boardroom on 25 September 2018. This second installment of an exclusive two-part interview with Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), defines ‘fair pricing’, gives IFPMA’s take on so-called “cost-plus” pricing models, and talks about access ...
Read More
20 September 2018 - By Thomas B. Cueni
This interview was first published on Pharma Boardroom on 18 September 2018. In this first installment of an exclusive two-part interview, IFPMA’s Thomas Cueni expounds on how IFPMA has grown from an association of associations to also include companies as members, key milestones in the organization’s 50 years of existence, ...
Read More
14 September 2018 - By Thomas B. Cueni
This blog was first published on the Diplomatic Courier on 13 September 2018   The alarm has rightly been sounded on a silent killer. Faced with the staggering figure that 40 million people lose their lives each year to non-communicable diseases (NCDs), it is time to leave our comfort zones ...
Read More
13 August 2018 - By Thomas B. Cueni
This blog piece has been first published in Africa Health Journal, July 2018 Latest Ebola response holds key to global health security Thomas Cueni discusses the important role of immunisation and the critical role of the pharmaceutical industry in combatting new threats such as with Ebola The recent deadly outbreak ...
Read More
12 July 2018 - By Thomas B. Cueni
This letter was first published on the Financial Times on 4th July 2018, in response to the article titled "Pharma sector failing to tackle superbugs, says O’Neill" (26th June 2018)   I respectfully disagree with Jim O’Neill’s comments on pharmaceutical companies’ inaction on combating antimicrobial resistance (“ Pharma sector failing ...
Read More
29 June 2018 - By Thomas B. Cueni
This blog was first published on the Media Planet supplement for the Guardian on 27 June 2018   Last month, President Kagame told the World Health Assembly: “In Rwanda, a combination of community-based health insurance, community health workers, and good external partnerships led to the steepest reductions (a halving) in ...
Read More